
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health Inc. is experiencing substantial growth, evidenced by a 53.3% increase in revenue and a 23-point expansion in adjusted operating margins year-over-year, highlighting the effectiveness of its strategic initiatives. The company projects an adjusted operating income margin of approximately 22.4% for the fourth quarter of 2025, indicating operational efficiency improvements tied to investments in marketing strategies and new programming. Furthermore, Hinge Health's current penetration rate of eligible clients is significantly lower than traditional physical therapy, suggesting considerable growth opportunities as it enhances tools like Hinge Connect to drive higher yields and member engagement.
Bears say
Hinge Health Inc. is experiencing a concerning decline in adjusted research and development expenses as a percentage of revenue, dropping from 23.7% in 3Q24 to 14.5% in 3Q25, which raises questions about future innovation and competitiveness. Additionally, management's guidance indicating a shift to mid-teens EBIT margins in the second half of 2025 suggests a deterioration in profitability, with FY26 and FY27 expectations remaining low at 14.6% and 16.2%, respectively. Furthermore, the anticipated sequential decline in membership in 4Q25, combined with reduced marketing spending due to expected lower ROI during holiday seasonality, casts further doubt on the company’s ability to sustain growth momentum.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares